PORTLAND, Ore. – Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, announced today that it has entered into a multi-year agreement with global healthcare supplier Perrigo Company plc to promote the ilast® range of products for eyelid hygiene in the United States.
“The ilast® brand is an integral part of our portfolio of branded products,” said Patrick Witham, President and CEO of Paragon BioTeck, Inc. “By expanding our promotional efforts to include marketing to clinically-relevant physicians, we hope to raise physician awareness about the importance of eyelid hygiene and the difference it can make for patients struggling with ocular surface disease.”
The ilast® family of products is scientifically formulated to contain high concentrations of Hyaluronic Acid. Available in two formulas, the ilast® product offering for eyelid hygiene includes ilast Care® and ilast Clean®, both 100% preservative free with Epifree® Technology, and fragrance and paraben free.
Join the conversation on Facebook and Twitter.
About Paragon BioTeck, Inc.
Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon’s portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. These products include the Comfortear® Lacrisolve™ Absorbable Punctum Plug, Comfortear® Punctum Plug, >, EqualEyes™ Ocular Lubricant, the preservative free ilast® range of products and their FDA approved Phenylephrine Hydrochloride Ophthalmic Solution available in 2.5% and 10%.
About Perrigo Company plc
Perrigo Company plc, a top five global over-the-counter (OTC) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world’s largest manufacturer of OTC products, and supplier of infant formulas for the store brand market. The Company is also a leading provider of generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other key markets including Israel and China.
For more information please call 888-424-1192 or email info@paragonbioteck.com.
